Showing 1001-1010 of 20877 results for "".
- SUBITO Trial Compares Intensified Chemotherapy With Olaparibhttps://reachmd.com/news/subito-trial-compares-intensified-chemotherapy-with-olaparib/2487896/Key Takeaways Overall survival findings were closely aligned between groups, with a reported hazard ratio for death of 1.11. Grade 3-4 cytopenias were common, serious adverse events occurred more often with intensified chemotherapy, and no treatment-re
- Study Identifies Key Trends in GLP-1–Related Plastic Surgery Researchhttps://reachmd.com/news/study-identifies-key-trends-in-glp-1related-plastic-surgery-research/2487864/The rapid adoption of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for medical weight management has fueled a surge of interest in their implications for aesthetic and reconstructive plastic surgery, according to a new bibliometric analysis published online ahead of print in Aestheti
- Deucravacitinib in Alopecia Areata: Phase II Trial Findingshttps://reachmd.com/news/deucravacitinib-phase-ii-trial-alopecia-areata/2487863/Key Takeaways Week-24 efficacy endpoints were not met, and secondary endpoints also did not differ from placebo. The phase II multicentre trial used double-blinded, placebo-controlled 1:1:1 randomization to placebo, deucravacitinib 6 mg once daily, or
- Allergan Aesthetics Invests in SkinMedica's Regenerative Science Strategyhttps://reachmd.com/news/allergan-aesthetics-invests-in-skinmedicas-regenerative-science-strategy/2487856/Allergan Aesthetics, an AbbVie company, announced a series of initiatives aimed at expanding SkinMedica's regenerative science platform, including the formation of a Regenerative Science Advisory Board, the expansion of its research and development laboratory, and the launch of physician-based fl
- Imaging-Guided Tape Stripping Standardizes Molecular Profiling in Pediatric Atopic Dermatitishttps://reachmd.com/news/imaging-guided-tape-stripping-standardizes-molecular-profiling-in-pediatric-atopic-dermatitis/2487887/A minimally invasive, imaging-guided tape-stripping technique may provide a standardized method for molecular profiling and treatment monitoring in pediatric atopic dermatitis (AD), according to findings published online ahead of print in the
- Nutrafol Study Reports Improved Hair Growth Rate and Scalp Coverage in Womenhttps://reachmd.com/news/nutrafol-study-reports-improved-hair-growth-rate-and-scalp-coverage-in-women/2487855/A new peer-reviewed study published in Dermatology and Therapy reported significant improvements in multiple objective measures of hair growth among women using Nutrafol Hair Growth Nutraceuticals over a 6-month treatment period. The prospective, open-label, randomized study enrol
- PD-1-Enhanced HIV-1 Therapeutic DNA Vaccine Shows Phase 1 Immunogenicityhttps://reachmd.com/news/pd-1-enhanced-hiv-1-therapeutic-dna-vaccine-shows-phase-1-immunogenicity/2487838/Key Takeaways This first-in-human, randomized, double-blind, placebo-controlled, dose-escalation phase 1 trial evaluated ICVAX in adults with HIV-1 on ART at Shenzhen Third People’s Hospital. Treatment-related adverse events occurred in 83.3% of ICVAX
- Guideline-Based Management Limits Testing and Identifies Risk Factors for Chronic Urticaria in Childrenhttps://reachmd.com/news/guideline-based-management-limits-testing-and-identifies-risk-factors-for-chronic-urticaria-in-children/2487889/Most children presenting with a first episode of acute urticaria (AU) recover with conservative, guideline-based management and require little diagnostic testing, according to a prospective cohort study published in Pediatric Allergy, Immunology, and Pulmonolog
- Zasocitinib Demonstrates Strong Week 16 Responses Across High-Impact Psoriasis Siteshttps://reachmd.com/news/zasocitinib-demonstrates-strong-week-16-responses-across-high-impact-psoriasis-sites/2487716/Takeda announced new secondary analyses from its pivotal Phase 3 LATITUDE PsO 3001 and 3002 trials showing that the investigational oral TYK2 inhibitor zasocitinib (TAK-279) achieved high rates of skin clearance in adults with moderate-to-severe plaque psoriasis a
- Text Messaging Intervention Improves Cardiovascular Risk Behaviors in PsO Trialhttps://reachmd.com/news/text-messaging-intervention-improves-cardiovascular-risk-behaviors-in-pso-trial/2487819/A structured text messaging intervention was shown to improve patient activation and several cardiovascular risk behaviors among adults with psoriasis, according to new findings published in JAMA Dermatology.